Evidence map›Paper›PMID 42567367›Full record

ArticleNeurobiology of disease2026

Selective impairment of long-term depression in accumbal D1R+ MSNs involves calcium-permeable AMPARs in early Alzheimer's disease.

Nicolas Riffo-Lepe, Juliana González-Sanmiguel, Isaías Meza, Paulina Saavedra-Sieyes, Lorena Armijo-Weingart, Helena Zambrano, Ailín Riquelme, Armando G Salinas, Loreto San Martín, Luis G Aguayo

Abstract read
In one paragraph

Article in Neurobiology of disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Nicolas Riffo-LepeLaboratorio de Neurofisiología, Departamento de Fisiología, Universidad de Concepción, Concepción, Chile. Electronic address: nriffo@udec.cl.
Juliana González-SanmiguelLaboratorio de Neurofisiología, Departamento de Fisiología, Universidad de Concepción, Concepción, Chile. Electronic address: jgonzalezsa@udec.cl.
Isaías MezaLaboratorio de Neurofisiología, Departamento de Fisiología, Universidad de Concepción, Concepción, Chile.
Paulina Saavedra-SieyesLaboratorio de Neurofisiología, Departamento de Fisiología, Universidad de Concepción, Concepción, Chile.
Lorena Armijo-WeingartLaboratorio de Neurofisiología, Departamento de Fisiología, Universidad de Concepción, Concepción, Chile; Facultad de Odontología, Universidad San Sebastián, Concepción, Chile. Electronic address: lorena.armijo@uss.cl.
Helena ZambranoLaboratorio de Neurofisiología, Departamento de Fisiología, Universidad de Concepción, Concepción, Chile. Electronic address: hezambrano2020@udec.cl.
Ailín RiquelmeLaboratorio de Neurofisiología, Departamento de Fisiología, Universidad de Concepción, Concepción, Chile. Electronic address: ariquelme2020@udec.cl.
Armando G SalinasDepartment of Pharmacology, Toxicology & Neuroscience, Louisiana State University Health Shreveport, Shreveport, LA, USA. Electronic address: armando.salinas@lsuhs.edu.
Loreto San MartínLaboratorio de Neurofisiología, Departamento de Fisiología, Universidad de Concepción, Concepción, Chile; Programa de Neurociencia, Psiquiatría y Salud Mental (NEPSAM), Universidad de Concepción, Concepción, Chile; Departamento de Bioquímica Clínica e Inmunología, Facultad de Farmacia, Universidad de Concepción, Concepción, Chile. Electronic address: loresanmartin@udec.cl.
Luis G AguayoLaboratorio de Neurofisiología, Departamento de Fisiología, Universidad de Concepción, Concepción, Chile; Programa de Neurociencia, Psiquiatría y Salud Mental (NEPSAM), Universidad de Concepción, Concepción, Chile. Electronic address: laguayo@udec.cl.

Funding

Mechanisms for potentiation of glycine receptors by ethanol.R01AA025718 · NIAAA · UNIVERSITY OF CONCEPCION · PI AGUAYO, LUIS GERARDO · 2017 to 2021
$1.1M
Potentiation of Glycine Receptors by EthanolR01AA015150 · NIAAA · UNIVERSITY OF CONCEPCION · PI AGUAYO, LUIS GERARDO · 2004 to 2010
$1.1M
NIAAA NIH HHS R01 AA015150NIAAA NIH HHS R01 AA025718
6 · The paper itself

Abstract

Alzheimer's disease (AD) is increasingly associated with early circuit dysfunction preceding cognitive decline, including neuronal hyperactivity and neuropsychiatric symptoms linked to mesolimbic pathways. The nucleus accumbens (NAc), a central regulator of reward and motivational processing, exhibits early alterations in excitation/inhibition balance in patients and experimental models, yet the synaptic mechanisms underlying its vulnerability remain unclear. Using a double transgenic APP/PS1 mice crossed with a Drd1a-tdTomato reporter line, we combined cell-type-specific electrophysiology, immunohistochemistry, ex vivo photometry, and behavioral assays. At a pre-plaque stage, intraneuronal Aβ accumulated in both dopamine D1 receptor-positive (D1R+) and D1R-negative medium spiny neurons (MSNs). Despite comparable Aβ levels, both high-frequency stimulation-induced long-term depression (LTD) and mGluR1/5-dependent LTD were selectively impaired in D1R+ MSNs. This vulnerability was accompanied by an increased contribution of calcium-permeable AMPA receptors (CP-AMPARs). Subsequent CP-AMPAR blockade reduced the residual evoked excitatory postsynaptic current that persisted after mGluR1/5 activation in APP/PS1 D1R+ MSNs. Because paired-pulse ratios remained unchanged, this residual response was consistent with a predominantly postsynaptic mechanism. These synaptic changes were accompanied by reduced evoked dopamine signaling, increased chocolate consumption, and altered baseline context preference, whereas standard pellet consumption, conditioned place preference, anxiety-like behavior, and social behavior were unchanged. These findings define a pre-plaque, cell-type-specific synaptic phenotype in male APP/PS1 mice in which impaired mGluR1/5-dependent plasticity and persistent CP-AMPAR signaling in D1R+ MSNs coincide with selective reward-related alterations.

Indexed as

Alzheimer DiseaseLong-Term Synaptic DepressionNucleus AccumbensReceptors, AMPAReceptors, Dopamine D1Amyloid beta-Protein PrecursorAnimalsCalciumMaleMedium Spiny NeuronsMiceMice, TransgenicReceptors, Metabotropic GlutamateAmyloid beta-Protein PrecursorCalciumReceptors, AMPAReceptors, Dopamine D1Receptors, Metabotropic GlutamateAlzheimer's diseaseAmyloid-betaCalcium-permeable AMPARsDopamine receptorLong-term depressionmGluRsNucleus accumbensSynaptic plasticity

Identifiers

PMID42567367
PMCPMC13635928

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.